The challenge of Metastatic colorectal cancer

被引:15
|
作者
Una Cidon, Esther [1 ]
机构
[1] Clin Univ Hosp, Dept Oncol, C Ramon & Cajal S-N, E-47005 Valladolid, Spain
关键词
colorectal cancer; metastatic colon cancer; panitumumab;
D O I
10.4137/CMO.S5214
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Colorectal cancer (CRC) is a very common disease with a high rate of mortality around the world, representing the second most frequent cause of cancer-related death. As the majority of patients are diagnosed with advanced cancer with a subsequent low five-year survival rate (10%), it is imperative to develop new strategies to treat this challenging patient population. Traditionally, patients received successive lines of chemotherapy and discontinued the treatment or switched to a different one in the event of disease progression. But despite the therapeutic advances achieved with combination chemotherapy regimens, particularly FOLFOX and FOLFIRI, considerable research has been necessary to further optimize chemotherapy for patients with metastatic colorectal cancer (mCRC). However, progress has been achieved over recent years. The most relevant relates to the approval of several new effective therapeutic drugs, such as monoclonal antibodies, which have greatly improved the outcomes for metastatic disease. The last agent approved has been panitumumab, which has been designed to target the epidermal growth factor receptor molecular pathway involved in the appearance and spread of cancer.
引用
收藏
页码:55 / 60
页数:6
相关论文
共 50 条
  • [1] BEVACIZUMAB IN METASTATIC COLORECTAL CANCER: MOROCCAN CHALLENGE
    Mouzount, H.
    Allam, W.
    Errihani, H.
    ANNALS OF ONCOLOGY, 2009, 20 : 73 - 73
  • [2] COLOMATE challenge to overcome resistance in metastatic colorectal cancer
    Yoshino, Takayuki
    ONCOLOGY-NEW YORK, 2021, 35 (10): : 656 - 657
  • [3] Peritoneal Metastasis: A Dilemma and Challenge in the Treatment of Metastatic Colorectal Cancer
    Xia, Wei
    Geng, Yiting
    Hu, Wenwei
    CANCERS, 2023, 15 (23)
  • [4] Chemotherapy re-challenge response rate in metastatic colorectal cancer
    Chambers, Alexandra E.
    Frick, Jacob
    Tanner, Natalee
    Gerkin, Richard
    Kundranda, Madappa
    Dragovich, Tomislav
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2018, 9 (04) : 679 - 686
  • [5] Re-challenge and the concept of lines of therapy in metastatic colorectal cancer
    de Gramont, Aimery
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S76 - S84
  • [6] Immune Checkpoint Inhibitors in pMMR Metastatic Colorectal Cancer: A Tough Challenge
    Marmorino, Federica
    Boccaccino, Alessandra
    Germani, Marco Maria
    Falcone, Alfredo
    Cremolini, Chiara
    CANCERS, 2020, 12 (08) : 1 - 27
  • [7] Colorectal cancer: The challenge
    Bleiberg, H
    EUROPEAN JOURNAL OF CANCER, 1996, 32A : S2 - S6
  • [8] CHALLENGE OF COLORECTAL CANCER
    MASON, AY
    PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1973, 66 (12): : 1177 - 1178
  • [9] Metastatic colorectal cancer
    Bouche, Olivier
    Conroy, Thierry
    Michel, Pierre
    Penna, Christophe
    Tournigand, Christophe
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2006, 30 : S30 - S42
  • [10] Metastatic colorectal cancer
    Kindler H.L.
    Shulman K.L.
    Current Treatment Options in Oncology, 2001, 2 (6) : 459 - 471